ÂÜÀòÂÒÂ×

Ole J. Dahlberg has a diverse range of work experience in various leadership roles. Ole J. is currently the Chairperson of the Board at NaDeNo Nanoscience AS, a nanotechnology drug delivery platform company. Prior to that, they served as the Chief Executive Officer at Curida and Curida Diatec, where they played a pivotal role in the growth and development of the company. Ole also worked as a Business Consultant at Canica Holding and held positions on the Board of Directors at DoMore Diagnostics, Caedo Oncology AS, GreinDX, and Oslo Cancer Cluster.

Before their time at Curida, Ole served as Vice President and General Manager at Thermo Fisher Scientific, where they were responsible for the Cell Biology division and managed a $1 billion business. Ole J. also held the role of Managing Director and Site Leader at Thermo Fisher Scientific Norway, where they successfully grew the business and built capabilities in research, diagnostics, and cell therapy.

Ole's expertise and experience extend beyond the biotech industry, as they have also served on the Board of Directors at Oslo Medtech. Overall, their extensive work experience demonstrates their strong leadership skills and ability to drive growth and innovation in various organizations.

Ole J. Dahlberg pursued their education from 1987 to 1990 at Nordstrand vg, although no specific degree or field of study is mentioned during this period. Later, from 1990 to 1997, they attended the University of Oslo (UiO) where they earned a Master's degree (Hovedfag) in General Genetics and Marine Biology.